Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Sacks

Showing results (341-350 of 346) with videos related to

Pageof 35
Sort By:
You have reached the last page of results.This site can display upto 346 results.
JAMA Oncology|September 15, 2022
Expanded Parameters in Active Surveillance for Low-risk Papillary Thyroid Carcinoma: A Nonrandomized Controlled TrialAllen S Ho, Sungjin Kim, Cynthia Zalt, et al.
Science Advances|July 3, 2026
Single-cell transcriptomic analysis reveals tumor-immune determinants of lymph node colonization and progression in thyroid cancerAnthony T Nguyen, Jolene Viramontes, Isaiah Vazquez, et al.
ESMO Open|March 15, 2021
Safety and activity of vandetanib in combination with everolimus in patients with advanced solid tumors: a phase I studyT Cascone, R L Sacks, I M Subbiah, et al.
Nature Genetics|May 16, 2019
The tomato pan-genome uncovers new genes and a rare allele regulating fruit flavorLei Gao, Itay Gonda, Honghe Sun, et al.
ACS Infectious Diseases|December 14, 2018
Drug Discovery for Kinetoplastid Diseases: Future DirectionsSrinivasa P S Rao, Michael P Barrett, Glenn Dranoff, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 20, 2026
SACI-IO HR+: A randomized phase II trial of sacituzumab govitecan with or without pembrolizumab in patients with metastatic hormone receptor-positive/HER2-negative breast cancerA C Garrido-Castro, S E Kim, T Li, et al.
Pageof 35

Showing results (341-350 of 346) with videos related to

Sort By:
Pageof 35
You have reached the last page of results.This site can display upto 346 results.
JAMA Oncology|September 15, 2022
Expanded Parameters in Active Surveillance for Low-risk Papillary Thyroid Carcinoma: A Nonrandomized Controlled TrialAllen S Ho, Sungjin Kim, Cynthia Zalt, et al.
Science Advances|July 3, 2026
Single-cell transcriptomic analysis reveals tumor-immune determinants of lymph node colonization and progression in thyroid cancerAnthony T Nguyen, Jolene Viramontes, Isaiah Vazquez, et al.
ESMO Open|March 15, 2021
Safety and activity of vandetanib in combination with everolimus in patients with advanced solid tumors: a phase I studyT Cascone, R L Sacks, I M Subbiah, et al.
Nature Genetics|May 16, 2019
The tomato pan-genome uncovers new genes and a rare allele regulating fruit flavorLei Gao, Itay Gonda, Honghe Sun, et al.
ACS Infectious Diseases|December 14, 2018
Drug Discovery for Kinetoplastid Diseases: Future DirectionsSrinivasa P S Rao, Michael P Barrett, Glenn Dranoff, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 20, 2026
SACI-IO HR+: A randomized phase II trial of sacituzumab govitecan with or without pembrolizumab in patients with metastatic hormone receptor-positive/HER2-negative breast cancerA C Garrido-Castro, S E Kim, T Li, et al.
Pageof 35